These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 37292686)
1. Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution. Lucas CH; Mirchia K; Seo K; Najem H; Chen W; Zakimi N; Choudhury A; Liu SJ; Phillips J; Magill S; Horbinski C; Solomon D; Perry A; Vasudevan H; Heimberger A; Raleigh D Res Sq; 2023 May; ():. PubMed ID: 37292686 [TBL] [Abstract][Full Text] [Related]
2. Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution. Lucas CG; Mirchia K; Seo K; Najem H; Chen WC; Zakimi N; Foster K; Eaton CD; Cady MA; Choudhury A; Liu SJ; Phillips JJ; Magill ST; Horbinski CM; Solomon DA; Perry A; Vasudevan HN; Heimberger AB; Raleigh DR Nat Genet; 2024 Jun; 56(6):1121-1133. PubMed ID: 38760638 [TBL] [Abstract][Full Text] [Related]
3. Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Choudhury A; Magill ST; Eaton CD; Prager BC; Chen WC; Cady MA; Seo K; Lucas CG; Casey-Clyde TJ; Vasudevan HN; Liu SJ; Villanueva-Meyer JE; Lam TC; Pu JK; Li LF; Leung GK; Swaney DL; Zhang MY; Chan JW; Qiu Z; Martin MV; Susko MS; Braunstein SE; Bush NAO; Schulte JD; Butowski N; Sneed PK; Berger MS; Krogan NJ; Perry A; Phillips JJ; Solomon DA; Costello JF; McDermott MW; Rich JN; Raleigh DR Nat Genet; 2022 May; 54(5):649-659. PubMed ID: 35534562 [TBL] [Abstract][Full Text] [Related]
4. Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma. Magill ST; Vasudevan HN; Seo K; Villanueva-Meyer JE; Choudhury A; John Liu S; Pekmezci M; Findakly S; Hilz S; Lastella S; Demaree B; Braunstein SE; Bush NAO; Aghi MK; Theodosopoulos PV; Sneed PK; Abate AR; Berger MS; McDermott MW; Lim DA; Ullian EM; Costello JF; Raleigh DR Nat Commun; 2020 Sep; 11(1):4803. PubMed ID: 32968068 [TBL] [Abstract][Full Text] [Related]
5. Spatial heterogeneity in DNA methylation and chromosomal alterations in diffuse gliomas and meningiomas. Ferreyra Vega S; Wenger A; Kling T; Olsson Bontell T; Jakola AS; Carén H Mod Pathol; 2022 Nov; 35(11):1551-1561. PubMed ID: 35701666 [TBL] [Abstract][Full Text] [Related]
6. NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapy. Choudhury A; Cady MA; Lucas CG; Najem H; Phillips JJ; Palikuqi B; Zakimi N; Joseph T; Birrueta JO; Chen WC; Bush NAO; Hervey-Jumper SL; Klein OD; Toedebusch CM; Horbinski CM; Magill ST; Bhaduri A; Perry A; Dickinson PJ; Heimberger AB; Ashworth A; Crouch EE; Raleigh DR bioRxiv; 2023 Jul; ():. PubMed ID: 37503127 [TBL] [Abstract][Full Text] [Related]
7. Perivascular NOTCH3+ Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy. Choudhury A; Cady MA; Lucas CG; Najem H; Phillips JJ; Palikuqi B; Zakimi N; Joseph T; Birrueta JO; Chen WC; Oberheim Bush NA; Hervey-Jumper SL; Klein OD; Toedebusch CM; Horbinski CM; Magill ST; Bhaduri A; Perry A; Dickinson PJ; Heimberger AB; Ashworth A; Crouch EE; Raleigh DR Cancer Discov; 2024 Oct; 14(10):1823-1837. PubMed ID: 38742767 [TBL] [Abstract][Full Text] [Related]
8. Landscape of genetic variants in sporadic meningiomas captured with clinical genomics. Leclair NK; Shen E; Wu Q; Wolansky L; Becker K; Li L; Bulsara KR Acta Neurochir (Wien); 2022 Sep; 164(9):2491-2503. PubMed ID: 35881312 [TBL] [Abstract][Full Text] [Related]
9. Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas. Mawrin C; Sasse T; Kirches E; Kropf S; Schneider T; Grimm C; Pambor C; Vorwerk CK; Firsching R; Lendeckel U; Dietzmann K Clin Cancer Res; 2005 Jun; 11(11):4074-82. PubMed ID: 15930342 [TBL] [Abstract][Full Text] [Related]
10. Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features. Choudhury A; Chen WC; Lucas CG; Bayley JC; Harmanci AS; Maas SLN; Santagata S; Klisch T; Perry A; Bi WL; Sahm F; Patel AJ; Magill ST; Raleigh DR Neuro Oncol; 2023 Mar; 25(3):520-530. PubMed ID: 36227281 [TBL] [Abstract][Full Text] [Related]
11. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation. Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203 [TBL] [Abstract][Full Text] [Related]
12. Genomic analysis of spinal meningiomas: correlation with histopathological grade. Driver J; Santagata S; Bi WL; Chi JH J Neurosurg Spine; 2023 Dec; 39(6):729-733. PubMed ID: 37728381 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery. Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463 [TBL] [Abstract][Full Text] [Related]
14. Emerging Medical Treatments for Meningioma in the Molecular Era. Nigim F; Wakimoto H; Kasper EM; Ackermans L; Temel Y Biomedicines; 2018 Aug; 6(3):. PubMed ID: 30082628 [TBL] [Abstract][Full Text] [Related]
15. In situ characterization of stem cells-like biomarkers in meningiomas. Alamir H; Alomari M; Salwati AAA; Saka M; Bangash M; Baeesa S; Alghamdi F; Carracedo A; Schulten HJ; Chaudhary A; Abuzenadah A; Hussein D Cancer Cell Int; 2018; 18():77. PubMed ID: 29849507 [TBL] [Abstract][Full Text] [Related]